Study of IBI3016 in People With Mild or Moderate Hypertension Patients

NCT07556796 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: IBI3016
OTHER: Placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.